| 1 |
Parvez MK, Sehgal D, Sarin SK, Basir SF, Jameel S. Inhibition of hepatitis B virus DNA replicative intermediate forms by recombinant interferon-γ. World J Gastroenterol 2006; 12(19): 3006-3014 [PMID: 16718779 DOI: 10.3748/wjg.v12.i19.3006] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 2 |
Di Bisceglie AM. Combination therapy for hepatitis B. Gut 2002;50:443-5. [PMID: 11889057 DOI: 10.1136/gut.50.4.443] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 3 |
Gerken G, Knolle P, zum Büschenfelde KM. Interferon Therapy of Viral Hepatitis. Symposium in Immunology V 1996. [DOI: 10.1007/978-3-642-79896-2_7] [Reference Citation Analysis]
|
| 4 |
Terrault N, Feinman SV. Interferons for viral hepatitis. Transfus Med Rev 1995;9:29-52. [PMID: 7536498 DOI: 10.1016/s0887-7963(05)80029-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 5 |
Lok AS. Treatment of chronic hepatitis B. J Viral Hepat 1994;1:105-24. [PMID: 8790566 DOI: 10.1111/j.1365-2893.1994.tb00110.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 6 |
Lau JY, Morris AG, Alexander GJ, Williams R. Interferon-gamma receptor expression in chronic hepatitis B virus infection. J Hepatol 1992;14:294-9. [PMID: 1323599 DOI: 10.1016/0168-8278(92)90173-m] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 7 |
Harrison TJ, Dusheiko GM. Hepatitis B virus and hepatitis delta virus. Mol Cell Biol Hum Dis Ser 1992;1:203-32. [PMID: 1341643 DOI: 10.1007/978-94-011-2384-6_7] [Reference Citation Analysis]
|
| 8 |
Lau JY, Bain VG, Naoumov NV, Smith HM, Alexander GJ, Williams R. Effect of interferon-gamma on hepatitis B viral antigen expression in primary hepatocyte culture. Hepatology 1991;14:975-9. [PMID: 1959885] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 9 |
Kakumu S, Ishikawa T, Mizokami M, Orido E, Yoshioka K, Wakita T, Yamamoto M. Treatment with human gamma interferon of chronic hepatitis B: comparative study with alpha interferon. J Med Virol 1991;35:32-7. [PMID: 1940881 DOI: 10.1002/jmv.1890350108] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 10 |
Harrison PM, Lau JY, Williams R. Hepatology. Postgrad Med J 1991;67:719-41. [PMID: 1754523 DOI: 10.1136/pgmj.67.790.719] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 11 |
Lau JY, Lai CL, Wu PC, Chung HT, Lok AS, Lin HJ. A randomised controlled trial of recombinant interferon-gamma in Chinese patients with chronic hepatitis B virus infection. J Med Virol 1991;34:184-7. [PMID: 1919540 DOI: 10.1002/jmv.1890340310] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 12 |
Chayama K, Saitoh S, Arase Y, Ikeda K, Matsumoto T, Sakai Y, Kobayashi M, Unakami M, Morinaga T, Kumada H. Effect of interferon administration on serum hepatitis C virus RNA in patients with chronic hepatitis C. Hepatology 1991;13:1040-3. [PMID: 1711001] [Cited by in Crossref: 116] [Cited by in F6Publishing: 94] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 13 |
Kakumu S, Ishikawa T, Wakita T, Yoshioka K, Ito Y, Shinagawa T. Effect of sizofiran, a polysaccharide, on interferon gamma, antibody production and lymphocyte proliferation specific for hepatitis B virus antigen in patients with chronic hepatitis B. Int J Immunopharmacol 1991;13:969-75. [PMID: 1761362 DOI: 10.1016/0192-0561(91)90050-h] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 14 |
Di Bisceglie AM, Rustgi VK, Kassianides C, Lisker-Melman M, Park Y, Waggoner JG, Hoofnagle JH. Therapy of chronic hepatitis B with recombinant human alpha and gamma interferon. Hepatology 1990;11:266-70. [PMID: 2106474 DOI: 10.1002/hep.1840110217] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 15 |
Hoofnagle JH. Alpha-interferon therapy of chronic hepatitis B. Current status and recommendations. J Hepatol 1990;11 Suppl 1:S100-7. [PMID: 2079565 DOI: 10.1016/0168-8278(90)90173-o] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 16 |
Idäpään-heikkilä J, Aranko K. Miscellaneous antibacterial and antiviral drugs. Side Effects of Drugs Annual 1990. [DOI: 10.1016/s0378-6080(05)80095-9] [Reference Citation Analysis]
|
| 17 |
Caselmann WH, Eisenburg J, Hofschneider PH, Koshy R. Beta- and gamma-interferon in chronic active hepatitis B. A pilot trial of short-term combination therapy. Gastroenterology 1989;96:449-55. [PMID: 2492011 DOI: 10.1016/0016-5085(89)91570-9] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 1.0] [Reference Citation Analysis]
|
